Real-World myeloma care under the microscope: 2,000 patients to shape future treatment

NCT ID NCT04888039

Recruiting now Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen May 19, 2026 · Last updated May 19, 2026

Summary

This study is following 2,000 people with multiple myeloma in the West-Occitanie region of France to see how they are actually treated in everyday medical practice, not just in controlled clinical trials. Researchers will track which drugs and procedures patients receive, how well they respond, and how their quality of life is affected. The goal is to understand what works best for different types of patients and to improve care for everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

IUCT-Oncopole - Toulouse University Hospital
RECRUITING

Toulouse, West-Occitanie, 31059, France

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA